The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

The global small molecule API market is on a trajectory of significant growth, with projections indicating an increase from $180.67 billion in 2022 to $193.62 billion in 2023, boasting a Compound Annual Growth Rate (CAGR) of 7.2%. Let’s delve into the factors fueling this growth and explore key trends shaping the landscape.

Small-Molecule Drugs Driving Demand

The surge in demand for small-molecule drugs is a pivotal factor propelling the small-molecule API market. These drugs, characterized by low molecular weight, play a crucial role in modulating biochemical processes for disease diagnosis, treatment, and prevention. Notably, in 2021, 75% of FDA-approved drugs were small molecules, with oncology dominating therapeutic applications. This trend is further buoyed by the contributions of small and mid-sized companies, relying on Contract Development and Manufacturing Organizations (CDMOs) for commercialization.

Market Players

Several major players steer the small molecule API market, underscoring the competitive landscape. Key industry contributors include Merck & Co., Inc., AbbVie, Inc., Bristol-Myers Squibb Company, Albemarle Corporation, Boehringer Ingelheim International GmbH, Dr. Reddy’s Laboratories Ltd., Aurobindo Pharma, and more.

Strategic Partnerships: A Key Trend

Strategic partnerships emerge as a prominent trend shaping the small-molecule API market. Companies are increasingly entering collaborations to fortify their positions and advance drug and therapy development. A notable instance is Pfizer Inc.’s partnership with PostEra in December 2020, focusing on accelerating small molecule drug discovery through generative chemistry. Similarly, Merck’s collaboration with Taiho Pharmaceutical Co., Ltd. in January 2020 underscores the industry’s emphasis on small-molecule inhibitors for cancer research.

Market Segmentation

Understanding the diverse facets of the small molecule API market is crucial. The market is segmented based on various parameters:

1) By Type

• Synthetic
• Biotech

2) By Manufacturer

• In-House
• Outsourced

3) By Application

• Cardiology
• Oncology
• CNS and Neurology
• Orthopaedic
• Endocrinology
• Other Applications

Regional Dynamics

Geographically, North America dominated the small molecule API market in 2022. However, the forecast suggests a dynamic shift, with Asia-Pacific poised to emerge as the fastest-growing region in the coming years.

Future Projections

Looking ahead, the small molecule API market is anticipated to continue its upward trajectory, reaching $246.18 billion in 2027 at a CAGR of 6.2%. The industry’s resilience and adaptability, coupled with the relentless pursuit of innovation, position it as a key player in the pharmaceutical landscape.

View More On The Small Molecule API Market Report 2023 – https://www.thebusinessresearchcompany.com/report/small-molecule-api-global-market-report

Request A Sample Of The Global Small Molecule API Market Report 2023:
https://www.thebusinessresearchcompany.com/sample_request?id=8236&type=smp

The Small Molecule API Global Market Report 2023  provides a comprehensive overview on the small molecule API market size, trends and drivers, opportunities, strategies, and companies analysis. Through our reports businesses can effectively analyze data and frame well-informed strategies 

View More Related Reports –
Bioanalytical Testing Services Global Market Report 2023
Leukemia Therapeutics Global Market Report 2023
Small Molecule Active Pharmaceutical Ingredient Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/ 
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company 
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model